- In a recent Nature article, MSKCC researchers in collaboration with researchers from several other institutions offered a genetic explanation for why people with lung cancer respond differently to erlotinib.
- James P. Allison, head of the immunology program at MSKCC, was quoted in a New York Times article about the recent FDA approved drug Yervoy, the first drug shown to prolong the lives of people with the skin cancer melanoma.
Author Archives: Mark
New AccessMedicine Resource
Sherris Medical Microbiology, 5e – this classic text gives you a solid grasp of the significance of etiologic agents, the pathogenic processes, epidemiology, and the basis of therapy for infectious diseases.
Micromedex 2.0 Now Available
Micromedex 2.0 is an updated interface that makes searching Micromedex easier and faster. The all new Micromedex 2.0 includes:
- Advanced search functionality
- Uncluttered, user-friendly interface
- Results ranked by relevance
- Direct links to summary-level and in-depth content
- Single results page with dosage, cautions, interactions, comparative efficacy, labeled and off-label indications, and more
- A 360 View Dashboard, which allows you to navigate through all parts of the site pertaining to one drug
- Use the Other Sources button found on each detail page to navigate to DRUGDEX, toxicology lookup or back to the 360 View Dashboard
- Mobile access via mobileMicromedex for the iPhone®, iPod Touch®, BlackBerry®, and other mobile devices